Assenagon Asset Management’s PMV Pharmaceuticals PMVP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $279K | Buy |
263,059
+148,021
| +129% | +$157K | ﹤0.01% | 1069 |
|
|
2025
Q1 | $125K | Sell |
115,038
-38,663
| -25% | -$42.1K | ﹤0.01% | 1106 |
|
|
2024
Q4 | $232K | Sell |
153,701
-200,136
| -57% | -$302K | ﹤0.01% | 1247 |
|
|
2024
Q3 | $527K | Buy |
353,837
+93,809
| +36% | +$140K | ﹤0.01% | 1201 |
|
|
2024
Q2 | $421K | Buy |
260,028
+189,214
| +267% | +$307K | ﹤0.01% | 1223 |
|
|
2024
Q1 | $120K | Hold |
70,814
| – | – | ﹤0.01% | 1308 |
|
|
2023
Q4 | $220K | Sell |
70,814
-187,724
| -73% | -$582K | ﹤0.01% | 1316 |
|
|
2023
Q3 | $1.59M | Sell |
258,538
-162,286
| -39% | -$996K | ﹤0.01% | 909 |
|
|
2023
Q2 | $2.63M | Hold |
420,824
| – | – | 0.01% | 654 |
|
|
2023
Q1 | $2.01M | Sell |
420,824
-20,479
| -5% | -$97.7K | 0.01% | 812 |
|
|
2022
Q4 | $3.84M | Sell |
441,303
-22,043
| -5% | -$192K | 0.01% | 572 |
|
|
2022
Q3 | $5.51M | Sell |
463,346
-166,193
| -26% | -$1.98M | 0.02% | 444 |
|
|
2022
Q2 | $8.97M | Sell |
629,539
-8,525
| -1% | -$121K | 0.03% | 370 |
|
|
2022
Q1 | $13.3M | Buy |
638,064
+532,980
| +507% | +$11.1M | 0.04% | 280 |
|
|
2021
Q4 | $2.43M | Buy |
105,084
+48,124
| +84% | +$1.11M | 0.01% | 720 |
|
|
2021
Q3 | $1.7M | Sell |
56,960
-107,526
| -65% | -$3.2M | 0.01% | 714 |
|
|
2021
Q2 | $5.62M | Buy |
+164,486
| New | +$5.62M | 0.02% | 428 |
|